>
pdufa.bio

TX2100

Updated ยทnext FDA decision on the calendar

TX2100 is a Tectonic Therapeutic, Inc. program. Its next catalyst is a Readout in Q3 2026. Every date links its source.

TECX catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Tectonic Therapeutic, Inc. (TECX). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Q3 2026TECX

Questions

When is TX2100's next FDA decision or readout?

The next tracked catalyst for TX2100 is a Readout in Q3 2026.

What happened at TX2100's most recent FDA decision?

No FDA decision for TX2100 is in our archive yet.

Who makes TX2100?

Tectonic Therapeutic, Inc. (TECX).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.